DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Schroeder AS, Kling T, Huss K, Borggraefe I, Koerte IK, Blaschek A, Jahn K, Heinen F, Berweck S.
Botulinum toxin type A and B for the reduction of hypersalivation in children with neurological disorders: a focus on effectiveness and therapy adherence.
Neuropediatrics 2012;
43: 27-36
We do not assume any responsibility for the contents of the web pages of other providers.